China Resources Pharmaceutical Group Ltd.
3320
Rang in aandelen
#4238
China Resources Pharmaceutical Group Limited, an investment holding company,... China Resources Pharmaceutical Group Limited, an investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally. It operates through four segments: Pharmaceutical Manufacturing, Pharmaceutical Distribution, Pharmaceutical Retail, and Others. The company offers a range of chemical drugs, Chinese medicines, and biological drugs, as well as nutritional and healthcare products for various therapeutic areas, including cardiovascular and cerebrovascular diseases, alimentary tract, endocrine diseases, respiratory diseases, orthopedics, nephrology, rheumatology and immunology, medical nutrition, pediatrics, genitourinary system, dermatological diseases, blood products, therapeutic infusions, antitumor drugs, medicine for cough and cold, anti-infection drugs, and psychoneurosis. It also provides warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical/medical device manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, the company is involved in property holding activities, as well as operates retail pharmacies under the Teck Soon Hong brands. It distributes its products under the 999, Dong-E-E-Jiao, Double Crane, Zizhu, Jiangzhong, Boya, and Kun Zhong Yao to hospitals and other medical institutions. The company was formerly known as China Resources Medications Group Limited and changed its name to China Resources Pharmaceutical Group Limited in December 2011. The company was incorporated in 2007 and is based in Wan Chai, Hong Kong. China Resources Pharmaceutical Group Limited is a subsidiary of CRH (Pharmaceutical) Limited.
Aandeelprijs
$0.59485697
Marktkapitalisatie
$3.74B
Verandering (1 dag)
0.98%
Verandering (1 jaar)
-2.72%
Land
HK
Handel China Resources Pharmaceutical Group Ltd. (3320)
Categorie
Healthcare
EPS voor China Resources Pharmaceutical Group Ltd. (3320)
EPS per June 2026 TTM: $0.10
Volgens de laatste financiële rapporten en de aandelenkoers van China Resources Pharmaceutical Group Ltd. is de huidige EPS van het bedrijf (TTM) $0.10. Eind 2023 had het bedrijf een EPS van $0.09, een stijging ten opzichte van de EPS van 2022 die $0.08 bedroeg.
EPS-geschiedenis van China Resources Pharmaceutical Group Ltd. van 2013 tot 2026
EPS aan het einde van elk jaar
| Jaar | EPS | Wijzigen |
|---|---|---|
| 2026 (TTM) | $0.10 | 37.00% |
| 2024 | $0.07 | -17.22% |
| 2023 | $0.09 | 3.08% |
| 2022 | $0.08 | 9.74% |
| 2021 | $0.08 | 14.75% |
| 2020 | $0.07 | 0.45% |
| 2019 | $0.07 | -18.24% |
| 2018 | $0.08 | 16.05% |
| 2017 | $0.07 | -4.22% |
| 2016 | $0.07 | -8.13% |
| 2015 | $0.08 | 44.40% |
| 2014 | $0.06 | -0.18% |
| 2013 | $0.06 | 0.00% |
EPS van vergelijkbare bedrijven of concurrenten
| Bedrijf | EPS | EPS-verschil | Land |
|---|---|---|---|
| $2.41 | 2,413.03% |
US
|
|
| - | - |
SE
|
|
| - | - |
FR
|
|
| - | - |
IT
|
|
| $0.02 | -80.40% |
HK
|
